WILLIAM C DOOLEY, MD
Radiology at 10 St, Oklahoma City, OK
License number
Oklahoma 21890
Category
Radiology
Type
Surgery
License number
Oklahoma 21890
Category
Radiology
Type
Surgical Oncology
Address
Address
825 NE 10Th St, Oklahoma City, OK 73104
Phone
(405) 271-7867
(405) 271-1515
(405) 271-1515
Personal information
See more information about WILLIAM C DOOLEY at radaris.comName
Address
Phone
520 S Coleman Ave, Hydro, OK 73048
419 NW 14Th St, Oklahoma City, OK 73103
2726 Amy Ct NE, Piedmont, OK 73078
Organization information
See more information about WILLIAM C DOOLEY at bizstanding.comCade Cancer Center - William C Dooley MD
825 NE 10 St #4500, Oklahoma City, OK 73104
Categories:
General Surgeons, Oncology Physicians & Surgeons, Physicians & Surgeons
Phone:
(405) 271-7867 (Phone)
Professional information
Dr. William C Dooley, Oklahoma City OK - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
Oklahoma Office
825 10Th SUITE 4500, Oklahoma City 73104
(405) 271-7867 (Phone), (405) 271-4443 (Fax)
Surgical Oncology @ OU
920 Stanton L Young Blvd, Oklahoma City 73104
(405) 271-7867 (Phone)
825 10Th SUITE 4500, Oklahoma City 73104
(405) 271-7867 (Phone), (405) 271-4443 (Fax)
Surgical Oncology @ OU
920 Stanton L Young Blvd, Oklahoma City 73104
(405) 271-7867 (Phone)
Procedures:
Biopsy, Biopsy of Breast, Brachytherapy, Breast Reconstruction, Breast Surgical Procedures, Chemotherapy, Excision of Breast Tumor, Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer, Incisional/Ventral Hernia Repair, Open, Lumpectomy, Lymph Node Biopsy or Excision, Mastectomy, Microwave Treatments, Partial Mastectomy, Port Placements or Replacements, Removal of Reproductive Organs (Hysterectomy, Oophorectomy, Salpingectomy, Salpingo-Oophorectomy, Resection of Peritoneal Malignancy), Splenectomy, Splenectomy and Splenorrhaphy, Stereotaxis
Conditions:
Breast Cancer, Breast Diseases, Breast Duct Papilloma, Breast Fibroadenoma, Breast Lump/Mass, Breast Tumor, Carcinoma in Situ, Cholecystitis and Gallstones, Colorectal Cancer, Incisional Hernia, Intestinal Obstruction, Lipomas, Lung Cancer, Malignant Tumor, Melanoma, Pancreatic Cancer, Peripheral Vascular Disease (PAD, PVD), Phlebitis and Thrombophlebitis, Pseudomyxoma Peritonei, Sarcoma, Secondary Malignancies, Soft Tissue Sarcoma
Certifications:
General Surgery, 2010
Awards:
Healthgrades Honor Roll, 2009 Commmission On Cancer Outstanding Liaison Physician Award, 10/2009, 2009 HOPE award- best small oncology practice nationwide, 2/2010, Otto Sartorius Lifetime Achievement Award for Innovations in Breast Cancer Research, 2/2011
Languages:
English, Spanish
Hospitals:
Oklahoma Office
825 10Th SUITE 4500, Oklahoma City 73104
Surgical Oncology @ OU
920 Stanton L Young Blvd, Oklahoma City 73104
OU Medical Center
1200 Everett Dr, Oklahoma City 73104
Saint Anthony Hospital
1000 North Lee Ave, Oklahoma City 73102
825 10Th SUITE 4500, Oklahoma City 73104
Surgical Oncology @ OU
920 Stanton L Young Blvd, Oklahoma City 73104
OU Medical Center
1200 Everett Dr, Oklahoma City 73104
Saint Anthony Hospital
1000 North Lee Ave, Oklahoma City 73102
Philosophy:
See web site www.oksurgonc.yourmd.com for full details
Education:
Medical School
Vanderbilt University School Of Medicine
Graduated: 1982
Johns Hopkins
Graduated: 1987
Oxford University
Graduated: 1986
Graduated: 1988
Vanderbilt University School Of Medicine
Graduated: 1982
Johns Hopkins
Graduated: 1987
Oxford University
Graduated: 1986
Graduated: 1988
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
6756200, Jun 29, 2004
Filed:
Jan 26, 2001
Appl. No.:
09/771357
Inventors:
Saraswati Sukumar - Columbia MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Assignee:
The Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RAR), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, and combinations of such genes serve as markers of breast malignancy.
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
6835541, Dec 28, 2004
Filed:
Jan 28, 2002
Appl. No.:
10/059579
Inventors:
Saraswati Sukumar - Columbia MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Mary Jo Fackler - Hunt Valley MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Mary Jo Fackler - Hunt Valley MD
Assignee:
The Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RAR), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.
William C Dooley, Oklahoma City OK
Specialties:
Surgeon
Address:
920 Stanton L Young Blvd, Oklahoma City, OK 73104
1122 Ne 13Th St, Oklahoma City, OK 73117
825 Ne 10Th St, Oklahoma City, OK 73104
1122 Ne 13Th St, Oklahoma City, OK 73117
825 Ne 10Th St, Oklahoma City, OK 73104
Education:
Vanderbilt University, School of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Surgical Oncology
Johns Hopkins Hospital - Residency - Surgery
John Radcliffe Hospital - Residency - Surgery
Johns Hopkins Hospital - Internship - Surgery
Johns Hopkins Hospital - Fellowship - Surgical Oncology
Johns Hopkins Hospital - Residency - Surgery
John Radcliffe Hospital - Residency - Surgery
Johns Hopkins Hospital - Internship - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
7858317, Dec 28, 2010
Filed:
Oct 9, 2008
Appl. No.:
12/248793
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William C. Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Jo Fackler - Hunt Valley MD, US
Ella Evron - Baltimore MD, US
William C. Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Jo Fackler - Hunt Valley MD, US
Assignee:
Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARĪ²), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
2005019, Sep 1, 2005
Filed:
Jun 18, 2004
Appl. No.:
10/872229
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Fackler - Hunt Valley MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Fackler - Hunt Valley MD, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARĪ²), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.